Abstract:Background: Hypersplenism remains a major problem in patients with chronic liver disease. For a long time splenectomy either open or laparoscopic was the definitive line of treatment for such conditions. However, sometimes the operation may be dangerous for some patients with poor liver condition and patients unfit for general anesthesia. So in the recent years partial splenic embolization (PSE) has been used as an alternative for splenectomy in such patients. Patients and methods: This comparative prospective study was conducted on 28 patients, with thrombocytopenia secondary to hypersplenism as the main clinical presentation, admitted to El-Demerdash and Ain Shams University Specialized hospitals between January 2015 and January 2017. They were classified into 2 groups A and B, with 14 patients in each group. Group A patients were treated by splenectomy, with prior upper GIT endoscopy to determine the presence of esophageal varices to be banded or ligated, while group B patients were treated by partial splenic embolization (PSE) aiming at establishing occlusion of 50-70% of the distal branches of the splenic artery. The study compared both groups as regard the improvement of the blood indices, RBC, TWBC and platelet count, length of hospital stay, and postoperative complications. Results: There was statistically significant difference among both groups as regards operative time, estimated blood loss, rate of blood transfusion and length of hospital stay. Multiple blood transfusions and blood loss was markedly increased in the splenectomy group. Postoperative complications were reported to be 78.6% in the splenectomy group, which was significantly higher than in the PSE group, 57.1% of patients. In all studied patients, all the indices of the blood count showed significantly increased postoperative values compared to the preoperative values at the one month follow up. The mean RBC count did not differ significantly between both study groups postoperatively, whereas the mean TWBC and platelet counts were significantly higher in the splenectomy group than in the PSE group (p < 0.05, p < 0.01). Conclusion: Both techniques are followed by marked improvement of the platelet count but improvement was much better after splenectomy. The study also presented PSE as a good therapeutic modality in patients with hypersplenism secondary to chronic liver disease with the advantages of being a simple procedure performed under local anesthesia with fewer post-procedure complications.

Partial splenic embolization with sodium alginate microspheres for hypersplenism in cirrhosis

Partial splenic embolization for liver cirrhosis accompanied by hypersplenism: an analysis of 39 cases

Clinical Evaluation on Effect of Partial Splenic Embolization in Treatment of 112 Patients with Hepatic Cirrhosis and Hypersplenism

Repeated partial splenic artery embolization for hypersplenism improves platelet count

Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.

Partial Splenic Embolization for Hypersplenism in Cirrhosis: A Long-Term Outcome in 62 Patients

Splenic partial embolization in treatment of hypersplenism using a mixture of silk threads and gelfoam

[Laparoscopic Splenectomy and Pericardial Devascularization for Treatment of Portal Hypertension Due to Liver Cirrhosis].

Effects Of Entecavir, Partial Splenic Artery Embolization, And Salvia Miltiorrhiza On Patients With Hypersplenism Due To Hepatitis B Virus-Related Cirrhosis

Short-term efficacy of splenectomy versus partial splenic embolization for liver cirrhosis and hypersplenism: a Meta-analysis

Partial splenic artery embolization for the treatment of patients with hypersplenism at high altitude region: clinical analysis

Partial Splenic Embolization Combined with Endoscopic Therapies and Vasoconstrictive Drugs Reduces Rebleeding in Cirrhosis Patients with Acute Variceal Bleeding and Hypersplenism: a Multicenter Randomized Controlled Trial

Splenic artery embolization with detachable balloons for hypersplenism

Analysis of early changes of hepatic blood flow after partial splenic embolization in 26 patients with liver cirrhosis and hypersplenism

Splenectomy versus Partial Splenic Artery Embolization for Management of Hypersplenism

Partial Splenic Artery Embolization to Treat Hypersplenism Secondary to Hepatic Cirrhosis: A Meta-Analysis

Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.

Safety and Efficacy of Splenic Artery Coil Embolization for Hypersplenism in Liver Cirrhosis

Clinical benefits of partial splenic embolization for cancer patients

Predictive Factors for Improving Thrombocytopenia and Risk Factors for Complications after Partial Splenic Embolization in Live Cirrhosis Patients

The application value of partial splenic embolization in the treatment of portal hypertension complicating other diseases